Ancient heat therapy tested to prevent post-transplant bladder pain

NCT ID NCT06198517

Recruiting now Prevention Sponsor: Yi Zhang Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether moxibustion, a traditional therapy that burns herbs near the skin, can prevent hemorrhagic cystitis (painful bladder inflammation) in 266 patients receiving stem cell transplants. Participants are randomly assigned to receive either standard care or standard care plus daily moxibustion for two weeks after transplant. Researchers will track pain scores and bladder symptoms for 100 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: moxibustion
What this could lead to: If it works, this could offer a simple, low-cost way to prevent a painful complication after stem cell transplant.
What could go wrong: This is an early-stage study without a placebo control, so results may be influenced by patient expectations. Moxibustion may not reduce pain or cystitis risk significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aplastic anemia Cystitis, Hemorrhagic hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm hemorrhagic cystitis prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC STEM CELL TRANSPLANTATION HEMORRHAGIC CYSTITIS MOXIBUSTION PREVENTION

Contacts and locations

Locations

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING

Hangzhou, Zhejiang, 311121, China
Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING

Zhengzhou, Henan, 450002, China
Hematology Department, The First People's Hospital of Yunnan
RECRUITING

Kunming, Yunnan, 650032, China
Yi Zhang
RECRUITING

Wuhan, Hubei, 430000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.